Hajissa, K.; Mussa, A.; Karobari, M.I.; Abbas, M.A.; Ibrahim, I.K.; Assiry, A.A.; Iqbal, A.; Alhumaid, S.; Mutair, A.A.; Rabaan, A.A.;
et al. The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development. Vaccines 2022, 10, 1346.
https://doi.org/10.3390/vaccines10081346
AMA Style
Hajissa K, Mussa A, Karobari MI, Abbas MA, Ibrahim IK, Assiry AA, Iqbal A, Alhumaid S, Mutair AA, Rabaan AA,
et al. The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development. Vaccines. 2022; 10(8):1346.
https://doi.org/10.3390/vaccines10081346
Chicago/Turabian Style
Hajissa, Khalid, Ali Mussa, Mohmed Isaqali Karobari, Muhammad Adamu Abbas, Ibrahim Khider Ibrahim, Ali A Assiry, Azhar Iqbal, Saad Alhumaid, Abbas Al Mutair, Ali A. Rabaan,
and et al. 2022. "The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development" Vaccines 10, no. 8: 1346.
https://doi.org/10.3390/vaccines10081346
APA Style
Hajissa, K., Mussa, A., Karobari, M. I., Abbas, M. A., Ibrahim, I. K., Assiry, A. A., Iqbal, A., Alhumaid, S., Mutair, A. A., Rabaan, A. A., Messina, P., & Scardina, G. A.
(2022). The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development. Vaccines, 10(8), 1346.
https://doi.org/10.3390/vaccines10081346
